SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Knighty Tin who wrote (69569)10/26/1999 2:39:00 PM
From: wiz  Read Replies (1) | Respond to of 132070
 
Mike

I've been following a biotech I like a lot. It soared after it's IPO, and has now settled back to that IPO price. It has even gone down below the level of a large private placement as of today. It has all been on low volume, and I still beieve in the company.
I know you don't like to follow technicals, or black magic, but is there a repeating patern biotechs follow along these lines? It seems other biotechs I have followed have had similar price action to this one.

Anyway, as far as buying. I would imagine this as good a time as any to buy my first third. Would you be looking for some other reason as to why this stock has dipped so low? (giving the market credit for being logical?)-g-

thanks,

mark



To: Knighty Tin who wrote (69569)10/26/1999 2:52:00 PM
From: Freedom Fighter  Read Replies (2) | Respond to of 132070
 
Mike,

The changes to the DOW should expand the PE of the index quite significantly. It'll be closer to the S&P500 now.
The expected growth rate in earnings should also be higher now.

I've been doing to some screens. The bloodshed is pretty bad once you get past the top companies.
There are tons of them down 30%-40% from their highs.

Wayne


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News